Abstract
Until 1984 AIDS science was open. Initially the new epidemic of pneumonias and Kaposi’s sarcomas, since called AIDS, was considered a collection of non-infectious ‘lifestyle’ diseases. But the Centers for Disease Control in Atlanta published that the pneumonias and Kaposi’s sarcomas of male homosexuals, who were addicted to recreational drugs, were caused by a common infectious agent because patients had been ‘linked’ by sexual contacts. On the basis of the CDC’s sexual linkage study, the Secretary of Health and Human Services announced in 1984 the hypothesis that the retrovirus HIV, is the cause of AIDS. The HIV-AIDS hypothesis currently holds a monopoly on all AIDS research and treatment. However, the HIV hypothesis is scientifically unproven. It has failed each of 15 testable predictions, as for example that AIDS would explode via sexual transmission of HIV into the general population. Moreover HIV meets all classical criteria of a harmless passenger virus: unpredictable intervals between infection and any subsequent disease, and unpredictable presence and activity of the virus during a disease. Since HIV is rare in the US, it is a marker of real AIDS risks, frequent injection of intravenous drugs, thousands of drug-mediated sexual contacts, and transfusions. Indeed, AIDS does not meet even one of the classical criteria of an infectious disease, as for example equal distribution between the sexes, disease within days or weeks after infection, and exponential spread of the disease in an un-immunized population (Farr’s law).
Far from being beneficial, the HIV-AIDS hypothesis has become a threat to public health in the last 10 years: It is the sole basis for (1) the daily treatment of at least 200 000 HIV-positives with cytotoxic DNA chain terminators originally designed to kill growing human cells for chemotherapy, like AZT, that are now prescribed as anti-HIV drugs; (2) the clean-needle programs that encourage intravenous drug use, and the misinformation that HIV-infection is the only health risk of recreational drug use. However, recreational drugs, such as heroin, cocaine, amphetamines and nitrite inhalants, have long been known to have immunotoxic, cytotoxic and/or carcinogenic effects; and (3) the anxiety and the many restrictions of human rights associated with a positive HIV-test.
Here it is proposed that American and European AIDS is caused by the long-term consumption of recreational and of anti-HIV drugs like AZT. The drug-AIDS hypothesis correctly predicts American/European AIDS: (1) AIDS is restricted to intravenous and oral users of recreational drugs and AZT; (2) AIDS is 87% male, because males consume this share of recreational drugs; (3) AIDS occurs in newborns because mothers use recreational drugs during pregnancy; (4) AIDS is new in America, because AIDS is a consequence of the recreational drug use epidemic that started in the 1960s, and of AZT prescriptions that started in 1987; (5) AIDS occurs only in a small fraction of recreational drug users, because only the highest life-time dose of drugs causes irreversible AIDS-defining diseases — likewise only the heaviest smokers get emphysema or lung cancer; (6) AIDS manifests as specific diseases in specific risk groups, because each group has specific drug habits. For example, pulmonary Kaposi’s sarcoma is exclusively diagnosed in male homosexuals who inhale carcinogenic alkyl nitrites; (7) AIDS does not occur in millions of HIV-positive non-drug users, and there are thousands of HIV-free AIDS cases, because AIDS is not caused by HIV; (8) AIDS is stabilized, even cured, if patients stop using recreational drugs or AZT — regardless of the presence of HIV. The drug hypothesis predicts that AIDS is an entirely preventable and in part curable disease. The solution to AIDS could be as close as a very testable and affordable alternative to the HIV hypothesis — the drug-AIDS hypothesis.
Chapter PDF
References
Adams, J., 1989. AIDS: The HIV Myth. St. Martin’s Press, New York.
AIDS Weekly, 1995. Government Congressman questions funding for AIDS research. AIDS Weekly May, 22:
Albert, J., H. Gaines, A. Sönnerborg, G. Nyström, P.O. Pehrson, F. Chiodi, M. von Sydow, L. Moberg, K. Lidman, B. Christensson, B. Åsjö & E.M. Fenyö, 1987. Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J. Med. Virol. 23: 67–73.
Altman, L.K., 1984. Researchers believe AIDS virus is found. New York Times, April 24, p CI,C3.
Altman, L.K., 1992. Working in public to explain AIDS-like ills. New York Times, Aug. 18, p B6.
Anderson, R.M. & R.M. May, 1992. Understanding the AIDS pandemic. Sci. Am. 266: 20–26.
Anonymous, 1992. Patient accuses Kaiser. Oakland Tribune December 1.
Archibald, C.P., M.T. Schechter, T.N. Le, K.J.P. Craib, J.S.G. Montaner & M.V. O’Shaughnessy, 1992. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi’s sarcoma in a cohort of homosexual men. Epidemiology 3: 203–209.
Ascher, M.S., H.W. Sheppard, W. Winklestein Jr & E. Vittinghoff, 1993. Does drug use cause AIDS? Nature (London) 362: 103–104.
Ashe, A. & A. Rampersad, 1993. Days of Grace. Alfred A. Knopf, New York.
Associated Press, 1994. Red Cross knew of AIDS blood threat. San Francisco Chronicle, May, 16, p A3.
Associated Press, 1995a. Signs that Ebola Virus is Fading Away. San Franscisco Chronicle, May 24, p A6.
Associated Press, 1995b. Study Find Ex-Smokers Still Risk Lung Cancer. San Francisco Chronicle, May 23, p A5.
Auerbach, D.M., W.W. Darrow, H.W. Jaffe & J.W. Curran, 1984. Cluster of cases of the Acquired Immune Deficiency Syndrome patients linked by sexual contact. Am. J. Med. 76: 487–492.
Bacellar, H., A. Munoz, E.N. Miller, B.A. Cohen, D. Besley, O.A. Seines, J.T. Becker & J.C. McArthur, 1994. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology 44: 1892–1900.
Bagasra, O., S.P. Hauptman, H.W. Lischner, M. Sachs & R.J. Pomerantz, 1992. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N. Engl. J. Med. 326: 1385–1391.
Baltimore, D. & M.B. Feinberg, 1989. HIV revealed, toward a natural history of the infection. N. Engl. J. Med. 321: 1673–1675.
Barre-Sinoussi, F., J.C. Chermann, E Rey, M.T. Nugeyre, S. Chamaret, C. Gruest, C. Dauget, C. Axler-Blin, F. VezinetBrun, C. Rouzioux, W. Rozenbaum & L. Montagnier, 1983. Isolation of a T-Iymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868–871.
Benditt, J. & B. Jasny, 1993. AIDS the unanswered questions. Science 260: 1219, 1253–1293.
Beral, V., T.A. Peterman, R.L. Berkelman & H.W. Jaffe, 1990. Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335: 123–128.
Bethell, T., 1994. Do ‘poppers’ hold the secret to one of the great mysteries of AIDS? Spin 10: 87–89, 116.
Blanche, S., M.-J. Mayaux, C. Rouzioux, J.-P. Teglas, G. Firtion, F. Monpoux, N. Ciraru-Vigneron, E Meier, J. Tricoire, C. Cour-potin, E. Vilmer, C. Griscelli, J.-F. Delfraissy and The French Pediatric HIV Infection Study Group, 1994. Relation of the Course of HIV Infection in Children to the Severity of the Disease in their Mothers at Delivery. The New England Journal of Medicine 330: 308–312.
Blattner, W.A., 1991. HIV epidemiology: past, present, and future. FASEB J. 5: 2340–2348.
Blattner, W.A., R.C. Gallo & H.M. Temin, 1988. HIV causes AIDS. Science 241: 514–515.
Booth, W., 1988. A rebel without a cause for AIDS. Science 239: 1485–1488.
Brandley, K., 1995. Crystal Symposium Next Thursday. Bay Area Reporter, March 2.
Bregman, D.J. & A.D. Langmuir, 1990. Farr’s law applied to AIDS projections. J. Am. Med. Assoc. 263: 50–57.
Bureau of Justice Statistics, 1991. Catalog of Federal Publications on Illegal Drug and Alcohol Abuse. U.S. Department of Justice, Washington D.C.
Callen, M., 1990. Surviving AIDS. Harper Perennial, New York.
Cao, Y., L. Quin, L. Zhang, J. Safrit & D.D. Ho, 1995. Virologie and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 Infection. N. Eng. J. Med. 332: 201–208.
Centers for Disease Control, 1987. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. J. Am. Med. Assoc. 258: 1143–1154.
Centers for Disease Control, 1993. U.S. AIDS cases reported through December 1992; year-end edition. HIV/AIDS Surveillance yearend edition: 1–23.
Centers for Disease Control, 1994. Heterosexually acquired AIDS-United States, 1993. Morb. Mortal. Weekly Reports 43: 155–160.
Centers for Disease Control, 1995. Update: Outbreak of Ebola viral hemorrhagic fever - Zaire, 1995. Morb. Mort. Weekly Reports. 44: 399.
Centers for Disease Control and Prevention, 1992.1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mort Weekly Rep 41 (No. RR17): 1–19.
Centers for Disease Control and Prevention, 1994a. U.S. HIV and AIDS cases reported through December 1993; Year-end Edition. HIV/AIDS Surveillance Report, p 1–33.
Centers for Disease Control and Prevention, 1994b. U.S. HIV and AIDS cases reported through December 1994. HIV/AIDS Surveillance Report 6: 1–39.
Centers for Disease Control and Prevention, 1994c. U.S. HIV and AIDS cases reported through June 1994, Mid-Year Edition. HIV/AIDS Surveillance Report 6: 1–27.
Champkin, J., 1994. Mother of courage. Daily Mail, December 5, p 41.
Chiu, D. & P. Duesberg, 1995. The Toxicity of Azidothymidine (AZT) on Human and Animal Cells in Culture at Concentrations Used for Antiviral Therapy. Genetica 95: 103–109.
Chorba, T.L., R.C. Holman, T.W. Strine, M.J. Clarke & B.L. Evatt, 1994. Changes in longevity and causes of death among persons with hemophilia A. Am. J. Hematol 45: 112–121.
Christie, H., 1994. Paradigms Lost. Continuum, Nov-Jan, p 11–13, 27–28,34–35.
Coffin, J., A. Haase, J.A. Levy, L. Montagnier, S. Groszlan, N. Teich, H. Temin, H. Varmus, P. Vogt & R. Weiss, 1986. Human immunodeficiency viruses. Science 232: 697.
Cohen, J., 1994a. The Duesberg Phenomenon. Science 266: 1642–1649.
Cohen, J., 1994b. Is a new virus the cause of KS? Science 266: 1803–1804.
Cohen, J., 1995. Researchers air alternative views on how HIV kills cells. Science 269: 1044–1045.
Cone, R.W., R.C. Hackman, M.-L. Huang, R.A. Bowden, J.D. Meyers, M. Metcalf, J. Zeh, R. Ashley & L. Corey, 1994. Human herpesvirus 6 in lung tissue from patients with pneumonia after bone marrow transplantation. N. Eng. J. Med. 329: 156–161.
Cox, G.D., 1986. County health panel urges `poppers’ ban, cites AIDS link. The Los Angeles Daily Journal, Mar. 24, p Section II, p.l.
Curran, J., D.N. Lawrence, H. Jaffe, J.E. Kaplan, L.D. Zyla, M. Chamberland, R. Weinstein, K.-J. Lui, L.B. Schonberger, T.J. Spira, W.J. Alexander, G. Swinger, A. Ammann, S. Solomon, D. Auerbach, D. Mildvan, R. Stoneburner, J.M. Jason, H.W. Haverkos & B.L. Evatt, 1984. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N. Engl. J. Med. 310:69–75.
Curran, J.W., M.W. Morgan, A.M. Hardy, H.W. Jaffe, W.W. Darrow & W.R. Dowdle, 1985. The epidemiology of AIDS: current status and future prospects. Science 229: 1352–1357.
Darrow, W.W., D.F. Echenberg, H.W. Jaffe, P.M. O’Malley, R.H. Byers, J.P. Getchell & J.W. Curran, 1987. Risk factors for human immunodeficiency virus (HIV) infections in homosexual men. Am. J. Publ. Health 77: 479–483.
Denetclaw, T.H. & W.F.J. Denetclaw, 1994a. Hantavirus pulmonary syndrome in New England and Europe. New Engl. J. Med. 331: 546–548.
Denetclaw, W.F. & T.H. Denetclaw, 19946. Is `south-west US mystery disease’ caused by Hantavirus? Lancet 343: 53–54. DeNoon, D.J., 1995. Duesberg Redux (Commentary). AIDS Weekly, January 9, p1–2.
Des Jarlais, D., S. Friedman, M. Marmor, H. Cohen, D. Mildvan, S. Yancovitz, U. Mathur, W. El-Sadr, T.j. Spira & J. Garber, 1987. Development of AIDS, HIV seroconversion and potential cofactors for T4 cell loss in a cohort of intravenous drug users. AIDS 1: 105–111.
Des Jarlais, D.C., S.R. Friedman, M. Marmor, D. Mildvan, S. Yancovitz, J.L. Sotheran, J. Wenston & S. Beatrice, 1993. CD4 Lymphocytopeniaamong injecting drug users in New York City. J. Acquir. Immune Defic. Syndr. 6: 820–822.
Dickson, D., 1994. Critic still lays blame for AIDS on lifestyle, not HIV. Nature (London) 369: 434.
Dietrich J., 1995. Der Tod aus dem Regenwald. Die Woche, 19 May, p26–27.
Donahoe, R.M., C. Bueso-Ramos, E. Donahoe, J.J. Madden, A. Falek, J.K.A. Nicholson & R Bokos, 1987. Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann. N.Y. Acad. Sci. 496: 711–721.
Drotman, D.P. & H. Haverkos, 1992. What Causes Kaposi’s Sarcoma? Inquiring Epidemiologists Want to Know. Epidemiology 3: 191–193. Drug Strategies, 1995. Keeping Score -What We Are Getting for Our Federal Drug Control Dollars. Washington.
Drotman, D.E, T.A. Peterman & A.E. Friedman-Kien, 1995. Kaposi’s sarcoma. How can epidemiology help find the cause? Dermatoepidemiology 13: 575–582.
Duesberg, P.H., 1987. Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res. 47: 1199–1220.
Duesberg, PH., 1989. Human immunodeficiency virus and acquired immunodeficiency syndrome: Correlation but not causation. Proc. Natl. Acad. Sci. USA 86: 755–764.
Duesberg, P.H., 1991. AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc. Natl. Acad. Sci. USA 88: 1575–1579.
Duesberg, P.H., 1992. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmacology & Therapeutics 55: 201–277.
Duesberg, P.H. & J.R. Schwartz, 1992. Latent viruses and mutated oncogenes: no evidence for pathogenicity. Prog. Nucleic Acid Res. Mol. Biol. 43: 135–204.
Duesberg, P., 1993a. Aetiology of AIDS. Lancet 341: 1544. Duesberg, P., 1993b. HIV and AIDS. Science 260: 1705.
Duesberg, P., 1993c. HIV and the aetiology of AIDS. Lancet 341: 957–958.
Duesberg, P.H., 1993d. Can epidemiology determine whether drugs or HIV cause AIDS? AIDS-Forschung 12: 627–635.
Duesberg, P.H., 1993e. HIV and AIDS. Science 260: 1705.
Duesberg, P.H., 1993f. The HIV gap in national AIDS statistics. Biotechnology 11: 955–956.
Duesberg, P.H., 1994a. Infectious AIDS - stretching the germ theory beyond its limits. Int. Arch. Allergy Immunol. 103: 131–142.
Duesberg, P.H., 1994b. Results fall short for HIV theory. Insight, February 14, p27–29.
Duesberg, P., 1995a. `The Duesberg-Phenomenon’: Duesberg and Other Voices (letter). Science 267: 313.
Duesberg, P., 1995b. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV. Genetica 95: 51–70.
Duesberg, P. & H. Bialy, 1995. Duesberg and the Right of Reply According to Maddox - Nature. In: AIDS: Infectious or Not?, Duesberg, P. (eds.) Kluwer, Dordrecht.
Eggers, H.J. & J.J. Weyer, 1991. Linkage and independence of AIDS Kaposi disease: The interaction of human immunodeficiency virus and some coagents. Infection 19: 115–122.
Ellison, B.J., A.B. Downey & P.H. Duesberg, 1995. HIV as a surrogate marker for drug-use: a re-analysis of the San Francisco Men’s Health Study. Genetica 95: 165–171.
Espinoza, P., I. Bouchard, C. Buffet, V. Thiers, J. Pillot & J.P. Etienne, 1987. High prevalence of infection by hepatitis B virus and HIV in incarcerated French drug addicts. Gastroenterologie Clinique et Biologique 11: 288–292.
European Collaborative Study, 1991. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 337: 253–260.
Evans, A.S., 1989. Does HIV cause AIDS? An historical perspective. J. Acquir. Immun Defic. Syndr. 2: 107–113.
Evatt, B.L., R.B. Ramsey, D.N. Lawrence, L.D. Zylä & J.W. Curran, 1984. The acquired immunodeficiency syndrome in patients with hemophilia. Ann. Inter. Med. 100: 499–505.
Farber, C., 1995a. AIDS - Words from the Front. SPIN Magazine April, p189–193,214–215.
Farber, C., 1995b. AIDS: Words from the front. SPIN, July, p69.
Fenner, E, B.R. McAuslan, C.A. Mims, J. Sambrook & D.O. White, 1974. The Biology of Animal Viruses. Academic Press. Inc., New York.
Fields, B.N., 1994. AIDS: time to turn to basic science. Nature (London) 369: 95–96.
Freeman, B.A., 1979. Burrows Textbook of Microbiology. W.B. Saunders and Co., Philadelphia.
Freiman, J.P., K.E. Helfert, M.R. Hamrell & D.S. Stein, 1993. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 7: 379–385.
Friedman-Kien, A.E., B.R. Saltzman, Y. Cao, M.S. Nestor, M. Mirabile, J.J. Li & T.A. Peterman, 1990. Kaposi’s sarcoma HIV-negative homosexual men. Lancet 335: 168–169.
Gaines, H., M. von Sydow, P.O. Pehrson &P. Lundbegh, 1988. Clinical picture of primary HIV infection presenting as a glandularfever-like illness. Br. Med. J. 297: 1363–1368.
Gallo, R.C., 1991. Virus Hunting-AIDS, Cancer & the Human Retrovirus: A Story of Scientific Discovery. Basic Books, New York.
Garay, S.M., M. Belenko, E. Fazzini & R. Schinella, 1987. Pulmonary manifestations of Kaposi’s sarcoma. Chest 91: 39–43.
Garza, B.W., D.P. Drotman & H.W. Jaffe, 1994. What Causes AIDS? The debate continues. Reason, December, p35.
Gavzer, B., 1995. Love has Helped Keep me Alive. Parade Magazine, April 16, p4–6.
Gettman, J., 1994. Heroin Returning to Center Stage. High Times, December, p23.
Gill, P.S., B. Akli, P. Coletti, M. Rarick, C. Louriero, M. Bernstein-Singer, M. Krailo & L.A.M., 1989. Pulmonary Kaposi’s sarcoma: clinical findings and results of therapy. Am. J. Med. 87: 57–61.
Gill, P.S., M. Rarick, R.K. Byrnes, D. Causey, C. Loureiro & A.M. Levine, 1987. Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 107: 502–505.
Goedert, J.J., A.R. Cohen, C.M. Kessler, S. Eichinger, S. V. Seremetis, C.S. Rabkin, F.J. Yellin, P.S. Rosenberg & L.M. Ale-dort, 1994. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Lancet 344: 791–792.
Goedert, J.J., C.Y. Neuland, W.C. Wallen, M.H. Greene, D.L. Mann, C. Murray, D.M. Strong, J.F. Fraumeni, Jr. & W.A. Blattner, 1982. Amyl nitrite may alter T lymphocytes in homosexual men. Lancet i: 412–416.
Gorman, P., 1994. Peter Duesberg: Visionary or Public Menace. High Times, December, p58–61, 66.
Goudsmit, J., 1992. Alternative view on AIDS. Lancet 339: 1289–1290.
Greenberg, D.S., 1986. What ever happened to the war on cancer? Discover, March, p47–66.
Gutknecht, G., 1995. Letter to Dr. Fauci. March 24, p.
Haverkos, H.W., 1990. Nitrite inhalant abuse and AIDS-related Kaposi’s sarcoma. J. Acquire. Immune Defic. Syndr. 3: Supplement 1, S47–S50.
Haverkos, H.W. & J.A. Doughherty (eds), 1988. Health Hazards of Nitrite Inhalants. NIDA Research Monograph 83, US. Dept. Health & Human Services, Washington, DC.
Haverkos, H.W. & D.P. Drotman, 1995. NIDA Technical Review: Nitrite Inhalants. NIDA, Washington, D.C. & CDC, Atlanta, GA, unpublished.
Haverkos, H.W., D.E. Drotman & D. Hanson, 1994. Surveillance for AIDS-related Kaposi’s sarcoma (KS): update. NIDA/CDC, Rockville, MD/Atlanta, GA, May.
Haverkos, H.W., P.F. Pinsky, D.P. Drotman & D.J. Bregman, 1985. Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi’s sarcoma. J. Sex. Trans. Dis. 12: 203–208.
Hearst, N. & S. Hulley, 1988. Preventing the heterosexual spread of AIDS: Are we giving our patients the best advice? J. Am. Med. Assoc. 259: 2428–2432.
Henry, K., 1995. Gutknecht stands by letter questioning link between HIV, AIDS. Star Tribune, May, 12, p 5A.
Hodgkinson, N., 1994. New Evidence links gay sex drug to AIDS. The London Sunday Times, April, 10, p 1–2.
Ho, D.D., 1995. Time to hit HIV, early and hard. N. Engl. J. Med. 333: 450–451.
Horwitz, J.E., J. Chua & M. Noel, 1964. Nucelosides. V. The monomesylates of 1-(2’-deoxy-beta-DIyxofuranosyl)thymidine. J. Org. Chem. 29: 2076.
Hughes, M.D., D.S. Stein, H.M. Gundacker, F.T. Valentine, J.P. Phair & P.A. Volberding, 1994. Within-Subject Variation in CD4 Lymphocyte Count in Asymptomatic Human Immunodeficiency Virus Infection: Implications for Patient Monitoring. J. Infectious Diseases 169: 28–36.
Institute of Medicine, 1988. Confronting AIDS-Update 1988. National Academy Press, Washington, DC.
Irwin, D.H. & L.D. Kaplan, 1993. Pulmonary manifestations of acquired immunodeficiency syndrome-associated malignancies. Seminars in Respiratory Infections 8: 139–148.
Jaffe, H.W., K. Choi, P.A. Thomas, H.W. Haverkos, D.M. Auerbach, M.E. Guinan, M.F. Rogers, T.J. Spira, W.W. Darrow, M.A. Kramer, S.M. Friedman, J.M. Monroe, A.E. Friedman-Kien, L.J. Laubenstein, M. Marmor, B. Safai, S.K. Dritz, S.J. Crispi, S.L. Fannin, J.P. Orkwis, A. Kelter, W.R. Rushing, S.B. Thacker & J.W. Curran, 1983. National case-control study of Kaposi’s sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 1, Epidemiologic results. Ann. Inter. Med. 99: 145–151.
Jacquez, J.A., J.S. Koopman, C.P. Simon & I.M. Longini Jr., 1994. Role of the primary infection in epidemics of HIV infection in gay chorts. J. Acquired Immune Deficiency Syndromes 7: 1169–1184.
Jones, M., 1994. Why Do Doctors Hate This Man? Genre, June, p39–43,97,100.
Kaiser, J., 1994. On-line journal to track new diseases. Science 266: 1935.
Kaldor, J.M., B. Tindall, R. Williamson, J. Elford & D.A. Cooper, 1993. Factors Associated with Kaposi’s Sarcoma in a Cohort of Homosexual and Bisexual Men. Journal of Acquired Immune Deficiency Syndromes 6: 1145–1149.
Kaposi, M., 1872. Idiopathisches multiples Pigmentsarkom der Haut. Archiv für Dermatologie and Syphilis 2: 265–273.
Karpas, A., M. Lowdell, S.K. Jacobson & F. Hill, 1992. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc. Natl. Acad. Sci. USA 89: 8351–8355.
Kaslow, R.A., W.C. Blackwelder, D.G. Ostrow, D. Yerg, J. Palenicek, A.H. Coulson & R.O. Valdiserri, 1989. No evidencefor a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals. J. Am. Med. Assoc. 261: 3424–3429.
Kaslow, R.A., J.P. Phair, H.B. Freidman, R.E. Lyter, R.E. Solomon, J. Dudley, F Polk & W. Blackwelder, 1987. Infection with the Human Immunodeficiency Virus: clinical manifestations and their relationship to immunodeficiency. Ann. Intern. Med. 107: 474–480.
Kessler, H.A., B. Blaauw, J. Spear, D.A. Paul, L.A. Falk & A. Lan-day, 1987. Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an active viral syndrome. J. Am. Med. Assoc. 258: 1196–1199.
Kolata, G., 1987. Imminent marketing of AZT raises problems; Marrow suppression hampers AZT use in AIDS victims. Science 235: 1462–1463.
Kumar, R.M., P.F. Hughes & A. Khurranna, 1994. Zidovudine Use in Pregnancy: A Report on 104 Cases and the Occurrence of Birth Defects. Journal of Acquired Immune Deficiency Syndromes 7: 1034–1039.
Lang, S., 1994. HIV and AIDS: Questions of Scientific and Journalistic Responsibility. Yale Scientific, Fall, p8–23.
Lang, W., R.E. Anderson, H. Perkins, R.M. Grant, D. Lyman, W. Winkelstein, R. Royce & J.A. Levy, 1987. Clinical, Immunologic and Serologic Findings in Men at Risk for Acquired Immunodeficiency Syndrome. J. Am. Med. Assoc. 257: 326–330.
Lang, W., H. Perkins, R.E. Anderson, R. Royce, N. Jewell & W. Winkelstein, Jr., 1989. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J. Acquir. Immun Defic. Syndr. 2: 63–69.
Larrat, P.E. & S. Zierler, 1993. Entangled epidemics: cocaine use and HIV disease. J Psychoactive drugs 25: 207–221.
Lauritsen, J., 1990. Poison by Prescription-The AZT Story. Asklepios Press, New York.
Lauritsen, J., 1992. FDA documents show fraud in AZT trials. New York Native, March 30, p 20–23.
Lauritsen, J., 1994. NIH reconsiders nitrites’ link to AIDS. Biotechnology 12: 762–763.
Lauritsen, J. & H. Wilson, 1986. Death Rush, Poppers and AIDS. Pagan Press, New York.
Lawrence, D.N., J.M. Jason, R.C. Holman & J.J. Murphy, 1990. HIV transmission from hemophilic men to their heterosexual partners. In: Heterosexual Transmission of AIDS, pp. 35–53, Alexander, N.J., Gabelnick, H.L. and Spieler, J.M. (eds.) Wiley-Liss, New York.
Layon, J., A. Idris, M. Warzynski, R. Sherer, D. Brauner, O. Patch, D. McCulley & P. Orris, 1984. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers. Arch. Intern. Med. 144: 1376–1380.
Learmont, J., B. Tindall, L. Evans, A. Cunningham, P. Cunningham, J. Wells, R. Penny, J. Kaldor & D.A. Cooper, 1992. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 340: 863–867.
Lemaître, M., D. Guetard, Y. Henin, L. Montagnier & A. Zerial, 1990. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Res. Virol. 141: 5–6.
Lenderking, W.R., R.D. Gelber, D.J. Cotton, B.F. Cole, A. Goldhirst, P.A. Volberding & M.A. Testa, 1994. Evaluation of the quality of life associated with Zidovudine treatment in asymptomatic Human Immunodeficiency Virus infection. N. Engl. J. Med. 330: 738–743.
Lerner, W.D., 1989. Cocaine abuse and acquired immunodeficiency syndrome: tale of two epidemics. Am. J. Med. 87: 661–663.
Lewis, A., 1994. Down the tabloid slope. New York Times, July 4, Monday, p 17.
Lewis, R.J.S., 1989. Food additives handbook. Van Nostrand Reinhold, New York, NY 10003.
Lewis-Thornton, R., 1994. Facing AIDS. Essence (New York), December, p63,64, 124, 126, 130.
Lifson, A.R., W.W. Darrow, N.A. Hessol, P.M. O’Malley, J.L. Barnhart, H.W. Jaffe & G.W. Rutherford, 1990. Kaposi’s sarcoma in a cohort of homosexual and bisexual men: epidemiology and analysis for cofactors. Am. J. Epidemiol. 131: 221–231.
Lockemann, U., R Wischhusen, K. Pueschel & et al. 1995. Vergleich der HIV-1-Praevalenz bei Drogentodesfaellen in Deutschland sowie in verschiedenen europaeischen Grosstaedten (Stand: 31.12. 1993). AIDS Forschung 10: 253–256.
Ludlam, C.A., 1992. AIDS: the alternative view (letter). Lancet 339: 1547–1548.
Maddox, J., 1991. AIDS research turned upside down. Nature (London) 353: 297.
Maddox, J., 1993a. Has Duesberg a right of reply? Nature (London) 363: 109.
Maddox, J., 1993b. New-style abuse of press freedom. Nature (London) 366: 493–494.
Maddox, J., 1995. Duesberg and the new view of HIV. Nature (London) 373: 189.
Mansfield, S. & G. Owen (1993). The use of Ecstasy and Other Recreational Drugs in Patients Attending an HIV Clinic in London and its Association with Sexual Behaviour. IX International Conference on AIDS, Berlin.
Marcus, R. and the CDC Cooperative Needlestick Surveillance Group, 1988. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N. Engl. J. Med. 319: 118–1123.
Marion, S.A., M.T. Schechter, M.S. Weaver, W.A. McLeod, W.J. Boyko, B. Willoughby, B. Douglas, K.J.P. Craib & M. O’Shaughnessy, 1989. Evidence that prior immune dysfunction predisposes to human immunodeficiency virus infection in homosexual men. J. Acquir. Immune Defic. Syndr. 2: 178–186.
Marmor, M., A.E. Friedman-Kien, L. Laubenstein, R.D. Byrum, D.C. William, S. D’Onofrio & N. Dubin, 1982. Risk factors for Kaposi’s sarcoma in homosexual men. Lancet i: 1083–1087.
Martin, D.J., J.G.M. Sim, G.J. Sole, L. Rymer, S. Shalekoff, A.B.N. van Niekerk, P. Becker, C.N. Weilbach, J. Iwanik, K. Keddy, G.B. Miller, B. Ozbay, A. Ryan, T. Viscovic & M. Woolf, 1995. CD4+ Lymphocyte count in African patients co-infected with HIV and tuberculosis. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8: 386–391.
Mathur-Wagh, U., R.W. Enlow, I. Spigland, R.J. Winchester, H.S. Sacks, E. Rorat, S.R. Yancovitz, M.J. Klein, D.C. Williams & D. Mildwan, 1984. Longitudinal study of persistent generalized lymphadenopathy in homosexual men: Relation to acquired immunodeficiency syndrome. Lancet i: 1033–1038.
McLeod, G.X. & S.M. Hammer, 1992. Zidovudine: Five Years Later. Ann. Intern. Med. 117: 487–501.
Meddis, S.V., 1994. Heroin use said to near crises level. USA Today, May 25, p 1, 3A.
Meduri, G.U., D.E. Stover, M. Lee, P.L. Myskowski, J.F. Caravelli & M.B. Zama, 1986. Pulmonary Kaposi’s sarcoma in the acquired immune deficiency syndrome: clinical, radiographic, and pathologic manifestations. Am. J. Med. 81: 11–18.
Merck Research Laboratories, 1992. The Merck Manual of Diagnosis and Therapy. Merck & Co., Inc., Rahway, NJ.
Merson, M.H., 1993. Slowing the spread of HIV: Agenda for the 1990’s. Science 260: 1266–1268.
Miami Herald, 1994. Woman wins $390 000 form HRS for AIDS misdiagnosis. Miami Herald, September 23, 1994, p Obituary page.
Mientjes, G.H.C., E.J.C. van Ameijden, H.M. Weigel, J.A.R. van der Hoek & R.A. Countinho, 1993. Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverts and infected and non-infected intravenous drug misusers. Br. Med. J. 306: 371–373.
Mims, C. & D.O. White, 1984. Viral Pathogenesis and Immunology. Blackwell Scientific Publications, Oxford.
Mir, N. & C. Costello, 1988. Zidovudine and bone marrow. Lancet ii: 1195–1196.
Mirken, B., 1995. Everything you always wanted to know about poppers; the `gay drug’ is still here despite a ban, and so is the controversy. San Francisco Frontiers Newsmagazine, July 20, p. 16–19.
Mirvish, S.S., J. Williamson, D. Babcook & C. Sheng-Chong, 1993. Mutagenicity of iso-butyl nitrite vapor in the Ames test and some relevant chemical properties, including the reaction of iso-butyl nitrite with phosphate. Environ. Mol. Mutagen. 21: 247–252.
Mok, J.Q., A. De Rossi, A.E. Ades, C. Giaquinto, I. Grosch-Woerner & C.S. Peckham, 1987. Infants born to mothers seropositive for human immunodeficiency virus. Lancet i: 1164–1168.
Moore, P.S. & Y. Chang, 1995. Detection of Herpesvirus-like DNA Sequences in Kaposi’s Sarcoma in Patients with and Those Without HIV Infection. N. Engl. J Med. 332: 1181–1185.
Moss, A.R., 1987. AIDS and intravenous drug use: the real heterosexual epidemic. Br. Med. J. 294: 389–390.
Moss, A.R., D. Osmond & P. Bacchetti, 1988. The cause of AIDS. Science 242: 997.
Mullis, K.B., 1995. A hypothetical disease of the immune system that may bear some relation to the Acquired Immune Deficiency Syndrome. Genetica 95a: 195–197.
Munoz, A., 1995. Disease progression 15 percent of HIV-infected men will be long-term survivors, AIDS Weekly, (News Report) May, 15 & 29: 5–6 & 3–4.
Murray, H.W., D.A. Scavuzzo, C.D. Kelly, B.Y. Rubin & R.B. Roberts, 1988. T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch. Intern. Med. 148: 1613–1616.
National Commission on AIDS, 1991. The Twin Epidemics of Substance Use and HIV. National Commission on AIDS, Washington, D.C., July.
National Institute of Allergy and Infectious Diseases, 1994. NIAID Backgrounder: How HIV Causes AIDS. NIH, Washington D.C., April.
National Research Council, 1982. Diet, nutrition, and cancer. National Acad. Press, Washington, D.C.
Newell, G.R., P.W.A. Mansell, M.R. Spitz, J.M. Reuben & E.M. Hersh, 1985a. Volatile nitrites: Use and adverse effects related to the current epidemic of the acquired immune deficiency syndrome. Am. J. Med. 78: 811–816.
Newell, G.R., P.W.A. Mansell, M.B. Wilson, H.K. Lynch, M.R. Spitz & E.M. Hersh, 1985b. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Preventative Med. 14: 81–91.
Nicolosi, A., M. Musico, A. Saracco, S. Molinari, N. Ziliani & A. Lazzarin, 1990. Incidence and risk factors of HIV infection: A prospective study of seronegative drug users from Milan and Northern Italy, 1987–1989. Epidemiology 1: 453–459.
Nieman, R.B., J. Fleming, R.J. Coker, J.R. Harris & D.M. Mitchell, 1993. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS 7: 705–710.
Niu, M.T., D.S. Stein & S.M. Schnittmann, 1993. Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retro-virus infections. J. Infect. Dis. 168: 1490–1501.
Nussbaum, B., 1990. Good Intentions: How Big Business, Politics, and Medicine are Corrupting the Fight Against AIDS. Atlantic Monthly Press, New York.
Oddone, E.Z., P. Cowper, J.D. Hamilton, D.B. Matchar, P. Hartigan, G. Samsa, M. Simberkoff & J.R. Feussner, 1993. Cost effectiveness analysis of early zidovudine treatment of HIV infected patients. Br. Med. J. 307: 1322–1325.
Oppenheimer, G.M., 1992. Causes, cases and cohorts. The role of epidemiology in the historical construction of AIDS. In: AIDS: The Making of a Chronic Disease, pp. 49–83, Fee, E. and Fox, D.M. (eds.) University of California Press, Berkeley.
Ostrow, D.G., 1994. Substance abuse and HIV infection. Psychiatric Manifestations of HIV Disease 17: 69–89.
Ostrow, D.G., M.J. Van Raden, R. Fox, L.A. Kingsley, J. Dudley, R.A. Kaslow and the Multicenter AIDS Cohort Study (MACS), 1990. Recreational drug use and sexual behaviour change in cohort of homosexual men. AIDS 4: 759–765.
Papadopulos-Eleopulos, E., V.F. Turner & J.M. Papadimitriou, 1993. Is a positive Western blot proof of HIV infection? Biotechnology 11: 696–707.
Parke, D., 1993. Key factor. The Sunday Times, Dec. 19, p letter.
Parker, W.B. & Y.C. Cheng, 1994. Mitochondrial toxicity of antiviral nucleoside analogs. The Journal of NIH Research 6: 57–61.
Pedersen, C., E. Dickmeiss, J. Gaub, L.P. Ryder, P. Platz, B.O. Lindhardt & J.D. Lundgren, 1990. T-cell subset alterations and lymphocyte responsiveness to mitogens and antigen during severe primary infection with HIV: a case series of seven consecutive HIV seroconverts. AIDS 4: 523–526.
Peterman, T.A., R.L. Stoneburner, J.R. Allen, H.W. Jaffe & J.W. Curran, 1988. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. J. Am. Med. Assoc. 259: 55–58.
Phair, J., L. Jacobson, R. Detels, C. Rinaldo, A. Saah, L. Schrager & A. Munoz, 1992. Acquired immune deficiency syndrome occuring within 5 yers of infection with human immunodeficiency virus type-1: The multicenter AIDS cohort study. J. Acquired Immune Deficiency Syndromes 5: 490–496.
Phillips, A.N., C.A. Sabin, J. Elford, M. Bofill, G. Janossy & C.A. Lee, 1994. Use of CD4 lymphocytes count to predict long term survival free of AIDS after HIV infection. Br. Med. J. 309: 309–313.
Physician’s Desk Reference, 1994. Retrovir. Medical Economics Co., Orandell, NJ.
Piatak, M., L.C. Saag, S.C. Yang, S.J. Clark, J.C. Kappes, K.-C. Luk, B.H. Hahn, G.M. Shaw & J.D. Lifson, 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749–1754.
Pillai, R., B.S. Nair & R.R. Watson, 1991. AIDS, drugs of abuse and the immune system: a complex immunotoxicological network. Arch. Toxicol. 65: 609–617.
Pluda, J.M., R. Yarchoan, E.S. Jaffe, I.M. Feuerstein, D. Solomon, S. Steinberg, K.M. Wyvill, A. Raubitschek, D. Katz & S. Broder, 1990. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann. Intern. Med. 113: 276–282.
Poznansky, M.C., R. Coker, C. Skinner, A. Hill, S. Bailey, L. Whitaker, A. Renton & J. Weber, 1995. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. Br. Med. J. 311: 156–158.
Project Inform, 1992. Is HIV the cause of AIDS? Project Discussion Paper #5, San Francisco, May 27, p 1–6.
Rappoport, J., 1988. AIDS INC. Human Energy Press, San Bruno, CA. Root-Bernstein, R.S., 1995a. The Duesberg Phenomenon’. What Does it Mean? (letter). Science 267: 159.
Rauschgiftbilanz 1994, 1995. Starke Nachfrage nach synthetischen Drogen. Deutsches Aerzteblatt 92: C-422.
Root-Bernstein, R.S., 1995b. Five myths about AIDS that have misdirected research and treatment. Genetica 95: 111–132.
Rosenberg, M.J. & J.M. Weiner, 1988. Prostitutes and AIDS: A health department priority? Am. J. Public Health 78: 418–423.
Rubinstein, E., 1990. II: The untold story of HUT78. Science 248: 1499–1507.
Saah, A.J., D.R. Hoover, Y. Peng, J.P. Phair, B. Visscher, L.A. Kingsley, L.K. Schrager and for the Multicenter AIDS Cohort Study, 1995. Predictiors for failure of Pneumocystis carinü pneumonia prophylaxis. J. Am. Med. Assoc. 273: 1197–1202.
Sadownick, D., 1994. Kneeling at the Crystal Cathedral. Genre, December/January 1994, p40–45,86–90.
San Francisco Project Inform, 1992. HIV=AIDS? Part One: Is HIV the Cause of AIDS? Part Two: How Does HIV Cause AIDS? San Francisco Project Inform, June 25, 1992.
Savona, S., M.A. Nardi, E.T. Lenette & S. Karpatkin, 1985. Thrombocytopenic purpura in narcotics addicts. Ann. Intern. Med. 102: 737–741.
Schechter, M.T., K.J.P. Craib, K.A. Gelmon, J.S.G. Montaner, T.N. Le & M.V. O’Shaughnessy, 1993a. HIV-1 and the aetiology of AIDS. Lancet 341: 658–659.
Schechter, M.T., K.J.P. Craib, K.A. Gelmon, J.S.G. Montaner, T.N. Le & M.V. O’Shaughnessy, 1993b. HIV-1 and the aetiology of AIDS. Lancet 341: 658–659.
Schechter, M.T., K.J.P. Craib, J.S.G. Montaner, T.N. Le, M.V. O’Shaughnessy & K.A. Gelmon, 1993e. Aetiology of AIDS. Lancet 341: 1222–1223.
Schmalz, J., 1992a. Covering AIDS and Living it: A Reporter’s Testimony. New York Times, December 20, p Sec 4.
Schmalz, J., 1992b. Holidays and the bad tidings of H.I.V. (personal story of Jeannie Pejko, who has AIDS). New York Times, 31 December, p A20 (L).
Schoch, R., 1994. A conversation with Kary Mullis. California Monthly 105: 16–21.
Schuster, C.R., 1984. Foreword. In: Cocaine: Pharmacology, Effects and Treatment of Abuse, NIDA Research Monograph 50, pp. VII-VIII, Grabowski, J. (eds.) National Institute on Drug Abuse, Washington, DC.
Scolaro, M., R. Durham & G. Pieczenik, 1991. Potential molecular competitor for HIV. Lancet 337: 731–732.
Seidman, S.N. & R.O. Rieder, 1994. A Review of Sexual Behaviour in the United States. The American Journal of Psychiatry 151: 330–341.
Seligmann, M., L. Chess, J.L. Fahey, A.S. Fauci, P.J. Lachmann, J. L’Age-Stehr, J. Ngu, A.J. Pinching, F.S. Rosen, T.J. Spira & J. Wybran, 1984. AIDS-an immunologic reevaluation. N. Eng. J. Med. 311: 1286–1292.
Seligmann, M., D.A. Warrell, J.-P. Aboulker, C. Carbon, J.H. Darbyshire, J. Dormont, E. Eschwege, D.J. Girling, D.R. James, J.-P. Levy, P.T.A. Peto, D. Schwarz, A.B. Stone, I.V.D. Weller, R. Withnall, K. Gelmon, E. Lafon, A.M. Swart, V.R. Aber, A.G. Babiker, S. Lhoro, A.J. Nunn &M. Vray, 1994. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343: 871–881.
Seremetis, S.V., L.M. Aledort, G.E. Bergman, R. Bona, G. Bray, D. Brettler, M.E. Eyster, C. Kessler, T.-S. Lau, J. Lusher & F. Rickles, 1993. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropostive haemophiliacs: effects on immune status. Lancet 342: 700–703.
Shilts, R., 1987. An the Band Played On. St. Martin’s Press, New York.
Simmonds, P., P. Balfe, J.F. Peutherer, C.A. Ludlam, J.O. Bishop &A.J. Leigh-Brown, 1990. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64: 864–872.
Sloand, E., P.N. Kumar & P.F. Pierce. 1993. Chemotherapy for patients with pulmonary Kaposi’s sarcoma: benefit of filgrastim (G-CSF) in supporting dose administration. Southern Medical Journal 86: 1219–1224.
Smith, G.D. & A.N. Phillips, 1992. Confounding in epidemiological studies: why `independent’ effects may not be all they seem. Br. Med. J. 305: 757–759.
Spornraft, P., M. Froschl, J. Ring, M. Meurer, F.D. Goebel, H.W. Ziegler-Heitbrock, G. Riethmuller & O. Braun-Falco, 1988. T4/T8 ratio and absolute T4 cell numbers in different clinical stages of Kaposi’s sarcoma in AIDS. Br. J. Dermatol. 119: 1–9.
Stehr-Green, J.K., J.M. Jason, B.L. Evatt and the Hemophilia-Associated AIDS Study Group, 1989. Geographic variability of hemophilia-associated AIDS in the United States: effect of population characteristics. Am. J. Hematol. 32: 178–183.
Stone, R., 1995. Congressman Uncovers the HIV Conspiracy. Science 268: 191.
Stoneburner, R.L., D.C. Des Jarlais, D. Benezra, L. Gorelkin, J.L. Sotheran, S.R. Friedman, S. Schultz, M. Marmor, D. Mildvan & R. Maslansky, 1988. A larger spectrum of severe HIV-I-related disease in intravenous drug users in New York City. Science 242: 916–919.
Swinbanks, D., 1994. AIDS chief promises a shift towards basic research. Nature (London) 370: 494.
The European Collaborative Study, 1994. Natural History of Vertically Acquired Human Immunodeficiency Virus-1 Infection. Pediatrics 94: 815–819.
The Lancet, 1994. Zidovudine for mother, fetus, and child: hope or poison? Lancet 344: 207–209.
Thomas, D., 1995. Risky Business. Men’s Style, May/June, p54/56, 102–106.
Thomas, Jr., C.A., K.B. Mullis & P.E. Johnson, 1994. What causes AIDS? Reason, June, p 18–23.
Till, M. & K.B. MacDonnell, 1990. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine? Ann. Intern. Med. 113: 492–494.
Tindall, B., D.A. Cooper, B. Donovan & R. Penny, 1988. Primary human immunodeficiency virus infection. Clinical and serologic aspects. Infectious Disease Clinics of North America 2: 329–341.
Tokars, J.I., R. Marcus, D.H. Culver, C.A. Schable, P.S. McKibben, C.I. Bandea & D.M. Bell, 1993. Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-infected Blood. Ann. Inter. Med. 118: 913–919.
Volberding, P.A., S.W. Lagakos, J.M. Grimes, D.S. Stein, J. Rooney, T.-C. Meng, M.A. Fischl, A.C. Collier, J.P. Phair, M.S. Hirsch, W.D. Hardy, H.H. Balfour, R.C. Reichmanand for the AIDS Clinical Trials Group, 1995. A comparison of immediate with deferredZidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. N. Engl. J. Med. 333: 401–407.
Vollbrechtshausen, A., 1994. Drogen: Poppers, Speed und XTC: ‘Am Wochenende bin ich nicht auf dieser Welt’. Magnus (Germany), Februar, p 48–53.
Wade, N., 1995. Contrarians at the gate. The New York Times, Jan. 8, p 14.
Wain-Hobson, S., 1995. Virological mayhem. Nature (London) 373: 102.
Weber, R., W. Ledergerber, M. Opravil, W. Siegenthaler & R. Lüthy, 1990. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 301: 1362–1365.
Weil, A. & W. Rosen, 1983. Chocolate and morphine. Houghton Mifflin Co., Boston.
Weiss, R. & H. Jaffe, 1990. Duesberg, HIV and AIDS. Nature (London) 345: 659–660.
Weiss, R., N. Teich, H. Varmus &J. Coffin, 1985. Molecular Biology of RNA Tumor Viruses. Cold Spring Harbor Press, Cold Spring Harbor, NY.
Weiss, S.H., C. Weston Klein, R.K. Mayur, J. Besra & T.N. Denny, 1992. Idiopathic CD4+ T-lymphocytopenia. Lancet 340: 608–609.
Wells, J., 1993. We have to question the so-called `facts’. Capital Gay, August 20th, p 14–15.
Winter, R., 1989. A consumer’s dictionary of food additives. Crown Publishers, Inc. New York, NY 10022.
World Health Organization, 1995. The current Global Situation of the HIV/AIDS Pandemic. Geneva, Jan.
Wyatt, E.A., 1994. Rushing to Judgement. Barron’s, August, 15, p23–27.
Yarbo, S., 1994. Verdict in case of false HIV diagnosis yields more clients. The Daily Business Review, Nov. 18, p A14.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Duesberg, P.H. (1996). How much longer can we afford the AIDS virus monopoly?. In: Duesberg, P.H. (eds) AIDS: Virus- or Drug Induced?. Contemporary Issues in Genetics and Evolution, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1651-7_18
Download citation
DOI: https://doi.org/10.1007/978-94-009-1651-7_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-3961-8
Online ISBN: 978-94-009-1651-7
eBook Packages: Springer Book Archive